Marinus Pharmaceuticals Inc (MRNS) Rapporto sugli Utili - Previsioni e Surprise Ratio

Pubblicita'

Storico dei ricavi trimestrali

MRNS rapporto: 41%

100%

MRNS supera 14 di 34 ultime stime

Data del prossimo reportNov 12, 2024

Stimato per Q3 24:$-0.44

Cambiamenti implicati per il Q2 24:-26.67%

Cambiamenti implicati per il Q3 23:-27.87%

Periodo Bilanci	Data Riportata	EPS / Previsioni	Sorpresa
Q2 24	Aug 13, 2024	$-0.6 / $-0.59	$-0.01 / -1.69%
Q1 24	May 8, 2024	$-0.68 / $-0.68	$0 / -
Q4 23	Mar 5, 2024	$-0.74 / $-0.64	$-0.1 / -15.63%
Q3 23	Nov 7, 2023	$-0.61 / $-0.67	$0.06 / 8.96%
Q2 23	Aug 10, 2023	$-0.61 / $-0.76	$0.15 / 19.74%
Q1 23	May 11, 2023	$-0.67 / $-0.77	$0.1 / 12.99%
Q4 22	Mar 7, 2023	$-0.76 / $-0.91	$0.15 / 16.48%
Q3 22	Nov 7, 2022	$-0.35 / $0.25	$-0.6 / -240%

Fornitori di Dati: Xignite Logo